Abbott’s Epic Plus Tissue Valves Receives the US FDA’s Approval for the Treatment of Mitral or Aortic Valve Replacement
Shots: The US FDA has approved Abbott’s Epic Plus & Epic Plus Supra Stented Tissue valves to treat patients with aortic or MV disease who undergoes valve replacement surgery. The devices build off Abbott’s Epic surgical valve platform Abbott’s Epic valve including radiopaque markers helps to improve implantation & allows compatibility for future transcatheter valve […]